Benign Sweat-Gland Tubular Adenoma Harboring an MYBL1::NFIB Fusion Gene

Sweat gland (SG) neoplasms encompass a wide variety of benign or malignant adnexal skin tumors differentiating into the various segments of SG. Their diagnosis and classification are often difficult, and have relied mainly on histologic and immunohistochemical criteria. Several genomic alterations have been more recently discovered in SG tumors, and have been used as additional diagnostic criteria. Among them, fusions of the MYBL1 or the MYB gene (namely MYB::NFIB or MYBL1::NFIB) have been detected in a significant proportion of cutaneous and extracutaneous (breast and salivary gland) adenoid cystic carcinomas (AdCC), and have been regarded specific of this tumor type. We report here an exceedingly rare case of a benign neoplasm diagnosed as benign tubular SG adenoma that was unexpectedly found to harbor a MYBL1::NFIB fusion gene. This case expands the spectrum of SG tumors driven by fusions of MYBL1, and challenges the specificity of MYBL1 fusions for cutaneous AdCC.

Authors

Institutions

Publication Details

Journal
American Journal of Dermatopathology
Published
2026-01-05
DOI
https://doi.org/10.1097/dad.0000000000003208
Primary Topic
Cancer and Skin Lesions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Benign Sweat-Gland Tubular Adenoma Harboring an MYBL1::NFIB Fusion Gene

D. Jullien, Jean Kanitakis, Françoise Descôtes
American Journal of Dermatopathology
Cancer and Skin Lesions
article

Benign Sweat-Gland Tubular Adenoma Harboring an MYBL1::NFIB Fusion Gene

D. Jullien, Jean Kanitakis, Françoise Descôtes
article en

Abstract

Sweat gland (SG) neoplasms encompass a wide variety of benign or malignant adnexal skin tumors differentiating into the various segments of SG. Their diagnosis and classification are often difficult, and have relied mainly on histologic and immunohistochemical criteria. Several genomic alterations have been more recently discovered in SG tumors, and have been used as additional diagnostic criteria. Among them, fusions of the MYBL1 or the MYB gene (namely MYB::NFIB or MYBL1::NFIB) have been detected in a significant proportion of cutaneous and extracutaneous (breast and salivary gland) adenoid cystic carcinomas (AdCC), and have been regarded specific of this tumor type. We report here an exceedingly rare case of a benign neoplasm diagnosed as benign tubular SG adenoma that was unexpectedly found to harbor a MYBL1::NFIB fusion gene. This case expands the spectrum of SG tumors driven by fusions of MYBL1, and challenges the specificity of MYBL1 fusions for cutaneous AdCC.

American Journal of Dermatopathology
Hôpital Lyon Sud (FR), Hôpital Edouard Herriot (FR)
Openalex Percentile: Top 97%
Cancer and Skin Lesions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Benign Sweat-Gland Tubular Adenoma Harboring an MYBL1::NFIB Fusion Gene — D. Jullien, Jean Kanitakis, et al. · American Journal of Dermatopathology (2026) | TGRS Research Map | TGRS